Loading…

Effects on the hemostatic system and liver function in relation to Implanon ® and Norplant ® : A prospective randomized clinical trial

In this prospective randomized clinical trial, two long-term contraceptive implants were studied with respect to hemostasis and liver function in 86 healthy young women. The two implants used were Implanon®, containing the progestagen etonogestrel (the biologically active metabolite of desogestrel)...

Full description

Saved in:
Bibliographic Details
Published in:Contraception (Stoneham) 1998-08, Vol.58 (2), p.93-98
Main Authors: Egberg, Nils, van Beek, Agaath, Gunnervik, Christina, Hulkko, Seppo, Hirvonen, Erkki, Larsson-Cohn, Ulf, Bennink, HerjanCoelingh
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this prospective randomized clinical trial, two long-term contraceptive implants were studied with respect to hemostasis and liver function in 86 healthy young women. The two implants used were Implanon®, containing the progestagen etonogestrel (the biologically active metabolite of desogestrel) and Norplant®, the implant containing the progestagen levonorgestrel. The results of the trial showed that both implants had similar small effects on the hemostatic system that are not suggestive of a tendency towards thrombosis. The effect on liver function was characterized by increases in total bilirubin and γ-glutamyl transferase and decreases in alanine aminotransferase and aspartate aminotransferase.
ISSN:0010-7824
1879-0518
DOI:10.1016/S0010-7824(98)00070-5